Aft Pharmaceuticals Ltd (AFP)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 3.630 |
|---|---|
| 52-week range | 2.610 – 4.130 |
| Return, 1 month / 3 months | +5.5% / +10.3% |
| Return, 1 year / 3 years | +39.8% / +17.9% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 38.6% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 0.01M AUD |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aft Pharmaceuticals is a specialty pharmaceutical company based in New Zealand that develops, licenses and markets medicines. Its product range includes prescription and over-the-counter treatments, among them the Maxigesic pain relief brand, and it also in-licenses medicines from other developers for local and regional distribution. The company supplies pharmacies, healthcare professionals and distributors, and its medicines reach customers in New Zealand, Australia and a number of international markets through licensing and distribution partners.
Aft Pharmaceuticals Ltd trades under the code AFP on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aft Pharmaceuticals Ltd (AFP) trades on the Australian Securities Exchange in Australia. It last closed at AUD 3.630 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 442 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.8% and over the last three months it rose 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.6% | ||
| From 52-week high | -11.5% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.3% | ||
| 6-month return | 15.8% | ||
| 12-month return, skipping the last month | 32.5% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M AUD | ||
| Zero-volume days | 33.3% | ||
| Income | 11 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | +5.5% |
| 3 months | +10.3% |
| 6 months | +15.8% |
| 1 year | +39.8% |
| 3 years | +17.9% |
| 5 years | −5.5% |
Signals
| 50-day / 200-day average | 3.585 / 3.252 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.035 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | NZD 0.0135 |
| 18 Jun 2025 | NZD 0.0111 |
| 19 Jun 2024 | NZD 0.0098 |
| 16 Jun 2023 | NZD 0.0069 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.